In vitro interaction of posaconazole and caspofungin against clinical isolates of Candida glabrata

被引：25
|
作者：
Oliveira, ER
Fothergill, AW
Kirkpatrick, WR
Coco, BJ
Patterson, TF
Redding, SW
机构：
[1] Univ Texas, Hlth Sci Ctr, Dept Gen Dent, San Antonio, TX 78229 USA
[2] Univ Texas, Hlth Sci Ctr, Dept Pathol, San Antonio, TX 78229 USA
[3] Univ Texas, Hlth Sci Ctr, Dept Med, Div Infect Dis, San Antonio, TX 78229 USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2005年 / 49卷 / 08期
关键词：
D O I：
10.1128/AAC.49.8.3544-3545.2005
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Combinations of caspofungin and posaconazole were evaluated by fractional inhibitory concentration index against 119 Candida glabrata isolates. Synergy was seen in 18% of all isolates and in 4% of fluconazole-resistant isolates at 48 h without evidence of antagonism. This antifungal combination may have utility against this organism.
引用
收藏
页码：3544 / 3545
页数：2
相关论文
共 50 条
  • [21] In vivo efficacy of anidulafungin and caspofungin against Candida glabrata and association with in vitro potency in the presence of sera
    Wiederhold, Nathan P.
    Najvar, Laura K.
    Bocanegra, Rosie
    Molina, Destiny
    Livo, Marcos
    Graybill, John R.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (05) : 1616 - 1620
  • [22] IN VITRO SYNERGISTIC ACTIVITY OF CASPOFUNGIN AND POLYMYXIN B AGAINST FLUCONAZOLE-RESISTANT CANDIDA GLABRATA
    Kelly, E. A.
    Ashcraft, D. S.
    Pankey, G. A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2015, 63 (02) : 472 - 472
  • [23] In Vitro Interaction of Itraconazole with Amphotericin B, Caspofungin, and Terbinafine Against Clinical Isolates of Trichosporon asahii
    Houmin Li
    Jianjun Qiao
    Zhe Wan
    Jianzhong Zhang
    Mycopathologia, 2011, 171 : 345 - 348
  • [24] In Vitro Interaction of Itraconazole with Amphotericin B, Caspofungin, and Terbinafine Against Clinical Isolates of Trichosporon asahii
    Li, Houmin
    Qiao, Jianjun
    Wan, Zhe
    Zhang, Jianzhong
    MYCOPATHOLOGIA, 2011, 171 (05) : 345 - 348
  • [25] Drug susceptibility profile of Candida glabrata clinical isolates from Iran and genetic resistant mechanisms to caspofungin
    Amanloo, Saeid
    Shams-Ghahfarokhi, Masoomeh
    Ghahri, Mohammad
    Razzaghi-Abyaneh, Mehdi
    REVISTA IBEROAMERICANA DE MICOLOGIA, 2018, 35 (02): : 88 - 91
  • [26] In vitro activity of amphotericin B, itraconazole, voriconazole, posaconazole, caspofungin and terbinafine against Scytalidium dimidiatum and Scytalidium hyalinum clinical isolates
    Lacroix, Claire
    de Chauvin, Martine Feuilhade
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (04) : 835 - 837
  • [27] In vitro susceptibility testing of flucytosine in combination with fluconazole against Candida glabrata isolates
    Linas, MD
    Cassaing, S
    Coste, A
    Seguela, JP
    JOURNAL DE MYCOLOGIE MEDICALE, 2003, 13 (04): : 181 - 185
  • [28] Synergistic effect of posaconazole and caspofungin against clinical zygomycetes
    Guembe, Maria
    Guinea, Jesus
    Pelaez, Teresa
    Torres-Narbona, Marta
    Bouza, Emilio
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (09) : 3457 - 3458
  • [29] Differential In Vivo Activities of Anidulafungin, Caspofungin, and Micafungin against Candida glabrata Isolates with and without FKS Resistance Mutations
    Arendrup, Maiken Cavling
    Perlin, David S.
    Jensen, Rasmus Hare
    Howard, Susan Julie
    Goodwin, Joanne
    Hope, William
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (05) : 2435 - 2442
  • [30] In vitro activity of Caspofungin combined with Fluconazole on mixed Candida albicans and Candida glabrata biofilm
    Pesee, Siripen
    Angkananuwat, Chayanit
    Tancharoensukjit, Sudarat
    Muanmai, Somporn
    Sirivan, Pattaraporn
    Bubphawas, Manita
    Tanarerkchai, Nissara
    MEDICAL MYCOLOGY, 2016, 54 (04) : 384 - 393
12345